US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

9.48

-0.2100-2.17%

Post-market: 9.800.3200+3.38%19:34 EDT

Volume:453.45K

Turnover:4.35M

Market Cap:435.10M

PE:-4.00

High:9.92

Open:9.78

Low:9.48

Close:9.69

52wk High:25.96

52wk Low:4.42

Shares:45.90M

Float Shares:37.58M

Volume Ratio:0.81

T/O Rate:1.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3710

EPS(LYR):-2.2432

ROE:-28.21%

ROA:-18.47%

PB:1.16

PE(LYR):-4.23

Loading ...

Overview Company News Filings

BioAge Labs to Present at Upcoming Investor Conferences

BTIG Initiates BioAge Labs at Buy With $40 Price Target

MT Newswires Live

BioAge Labs Initiated at Buy by BTIG

BioAge Labs initiated with a Buy at BTIG

Earnings Beat: BioAge Labs, Inc. (NASDAQ:BIOA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)

BioAge Labs posts R&D Day presentation on BGE-102 program

Calendar of U.S. Earnings Expected in the Week Ahead

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

BioAge Labs reports Q1 EPS (52c), consensus (63c)

BioAge Labs Reports Q1 GAAP Loss of $0.52 Per Share on $2.8 Million Revenue

BioAge Labs Q1 Loss Widens, Collaboration Revenue Rises

MT Newswires Live

Bioage Labs Q1 EPS $(0.52) Beats $(0.64) Estimate, Sales $2.772M Beat $1.083M Estimate

Benzinga Earnings

BioAge Labs Q1 collaboration revenue beats estimates on Novartis collaboration

Bioage Labs Inc Q1 Collaboration Revenue USD 2.772 Million VS. Ibes Estimate USD 1.32 Million

THOMSON REUTERS

Bioage Labs Inc Q1 EPS USD -0.52

THOMSON REUTERS

BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates

BioAge hosts R&D Day webcast on BGE-102 NLRP3 inhibitor program

BioAge Labs announces annual shareholder meeting notice

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Geron (GERN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BIOA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIOA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":9.48,"timestamp":1787342400000,"preClose":9.69,"halted":0,"volume":453445,"hourTrading":{"tag":"盘后","latestPrice":9.8,"preClose":9.48,"latestTime":"19:34 EDT","volume":2711,"amount":25729.7392,"timestamp":1787355281692,"change":0.32,"changeRate":0.033755,"amplitude":0.03903},"delay":0,"changeRate":-0.021671826625386904,"floatShares":37575608,"shares":45896909,"eps":-2.371024,"marketStatus":"Market Closed","change":-0.21,"latestTime":"08-21 16:00:00 EDT","open":9.78,"high":9.9164,"low":9.48,"amount":4352566.86227,"amplitude":0.045036,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.371024,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":9.69,"preHourTrading":{"tag":"盘前","latestPrice":9.72,"preClose":9.69,"latestTime":"08:29 EDT","volume":101,"amount":981.8693790000001,"timestamp":1787315373225,"change":0.03,"changeRate":0.003096,"amplitude":0.015418},"postHourTrading":{"tag":"盘后","latestPrice":9.8,"preClose":9.48,"latestTime":"19:34 EDT","volume":2711,"amount":25729.7392,"timestamp":1787355281692,"change":0.32,"changeRate":0.033755,"amplitude":0.03903},"volumeRatio":0.8144329638553844,"impliedVol":0.9602,"impliedVolPercentile":0.5976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","floatShares":37575608,"roa":"-18.47%","roe":"-28.21%","lyrEps":-2.243207,"volumeRatio":0.8144329638553844,"shares":45896909,"dividePrice":0,"high":9.9164,"amplitude":0.045036,"preClose":9.69,"low":9.48,"week52Low":4.42,"pbRate":"1.16","psRate":"42.02","week52High":25.955,"institutionHeld":0,"latestPrice":9.48,"eps":-2.371024,"divideRate":0,"volume":453445,"delay":0,"ttmEps":-2.371024,"open":9.78,"prevYearClose":13.23,"prevWeekClose":10.6,"prevMonthClose":9.04,"prevQuarterClose":24.51,"fiveDayClose":10.6,"twentyDayClose":21.77,"sixtyDayClose":16.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"BIOA","fiscalQuarterEnding":"2026/06","expectedEps":-0.65,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2026-05-08","symbol":"BIOA","fiscalQuarterEnding":"2026/03","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-03-24","symbol":"BIOA","fiscalQuarterEnding":"2025/12","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774324800000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-06","symbol":"BIOA","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-08-06","symbol":"BIOA","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.3333,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1779940800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIOA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIOA","date":"2026-08-21","current":-3.998272,"percent":0.477895,"low":-14.88445,"twenty":-10.461393,"median":-3.973853,"eighty":-2.193232,"high":-1.532635,"avg":-5.932623,"sd":3.991887,"marketCap":444741048},"quantilePoints":[{"date":"2024-09-27","current":-10.065016,"twenty":-9.996853,"median":-9.894609,"eighty":-9.328936,"marketCap":625601139},{"date":"2024-10-04","current":-11.466752,"twenty":-11.453559,"median":-10.988513,"eighty":-9.962772,"marketCap":712727458},{"date":"2024-10-11","current":-11.290848,"twenty":-11.83725,"median":-11.290848,"eighty":-10.377246,"marketCap":701793959},{"date":"2024-10-18","current":-13.247909,"twenty":-12.852074,"median":-11.505231,"eighty":-10.913754,"marketCap":823437060},{"date":"2024-10-25","current":-13.708907,"twenty":-13.699687,"median":-12.032944,"eighty":-11.062173,"marketCap":852090807},{"date":"2024-10-31","current":-14.198716,"twenty":-13.910593,"median":-12.258321,"eighty":-11.163318,"marketCap":882535413},{"date":"2024-11-08","current":-10.411209,"twenty":-13.841443,"median":-12.631325,"eighty":-11.163318,"marketCap":738550334},{"date":"2024-11-15","current":-9.850761,"twenty":-13.741177,"median":-12.203351,"eighty":-10.879672,"marketCap":698793259},{"date":"2024-11-22","current":-9.318711,"twenty":-13.704297,"median":-11.736106,"eighty":-10.071646,"marketCap":661050728},{"date":"2024-11-29","current":-9.500638,"twenty":-13.685857,"median":-11.456511,"eighty":-9.850761,"marketCap":673956274},{"date":"2024-12-06","current":-9.283336,"twenty":-13.657045,"median":-11.290848,"eighty":-9.500638,"marketCap":658541317},{"date":"2024-12-13","current":-2.319571,"twenty":-13.258776,"median":-11.073716,"eighty":-9.298497,"marketCap":164545707},{"date":"2024-12-20","current":-2.612676,"twenty":-13.247909,"median":-10.411209,"eighty":-9.141838,"marketCap":185337975},{"date":"2024-12-27","current":-2.971476,"twenty":-13.224859,"median":-10.152544,"eighty":-7.606575,"marketCap":210790579},{"date":"2025-01-03","current":-2.809763,"twenty":-13.09117,"median":-10.065016,"eighty":-3.032119,"marketCap":199318983},{"date":"2025-01-10","current":-2.572247,"twenty":-12.858367,"median":-9.894609,"eighty":-2.886577,"marketCap":182470076},{"date":"2025-01-17","current":-2.54698,"twenty":-12.632478,"median":-9.680039,"eighty":-2.714757,"marketCap":180677639},{"date":"2025-01-24","current":-2.678371,"twenty":-12.552115,"median":-9.568861,"eighty":-2.625815,"marketCap":189998311},{"date":"2025-01-31","current":-2.415588,"twenty":-12.247327,"median":-9.318711,"eighty":-2.600547,"marketCap":171356967},{"date":"2025-02-07","current":-2.309464,"twenty":-12.16927,"median":-9.263122,"eighty":-2.51868,"marketCap":163828732},{"date":"2025-02-14","current":-2.284196,"twenty":-12.012055,"median":-9.141838,"eighty":-2.417609,"marketCap":162036295},{"date":"2025-02-21","current":-2.223554,"twenty":-11.928501,"median":-8.818412,"eighty":-2.37516,"marketCap":157734447},{"date":"2025-02-28","current":-2.208393,"twenty":-11.54371,"median":-3.087708,"eighty":-2.319571,"marketCap":156658985},{"date":"2025-03-07","current":-2.269035,"twenty":-11.466752,"median":-2.971476,"eighty":-2.294303,"marketCap":160960833},{"date":"2025-03-14","current":-2.122483,"twenty":-11.446271,"median":-2.893147,"eighty":-2.269035,"marketCap":150564699},{"date":"2025-03-21","current":-2.208204,"twenty":-11.43377,"median":-2.779442,"eighty":-2.233661,"marketCap":157023162},{"date":"2025-03-28","current":-1.956126,"twenty":-11.290848,"median":-2.7188,"eighty":-2.233661,"marketCap":139098143},{"date":"2025-04-04","current":-1.714131,"twenty":-11.203915,"median":-2.693532,"eighty":-2.213447,"marketCap":121890125},{"date":"2025-04-11","current":-1.729255,"twenty":-11.131435,"median":-2.645523,"eighty":-2.198286,"marketCap":122965626},{"date":"2025-04-17","current":-1.890585,"twenty":-11.039085,"median":-2.589935,"eighty":-2.192221,"marketCap":134437638},{"date":"2025-04-25","current":-2.117456,"twenty":-10.879672,"median":-2.54698,"eighty":-2.170997,"marketCap":150570155},{"date":"2025-05-02","current":-2.087206,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"marketCap":148419153},{"date":"2025-05-09","current":-2.073948,"twenty":-10.229442,"median":-2.420641,"eighty":-2.117456,"marketCap":147343652},{"date":"2025-05-16","current":-1.927611,"twenty":-10.158835,"median":-2.377687,"eighty":-2.112406,"marketCap":136947141},{"date":"2025-05-23","current":-2.038626,"twenty":-10.109042,"median":-2.344838,"eighty":-2.086198,"marketCap":144834149},{"date":"2025-05-30","current":-2.008349,"twenty":-10.078276,"median":-2.334731,"eighty":-2.073148,"marketCap":142683147},{"date":"2025-06-06","current":-2.24047,"twenty":-9.99928,"median":-2.314518,"eighty":-2.051746,"marketCap":159174164},{"date":"2025-06-13","current":-2.2657,"twenty":-9.918948,"median":-2.294303,"eighty":-2.064674,"marketCap":160966666},{"date":"2025-06-20","current":-2.215239,"twenty":-9.87707,"median":-2.284196,"eighty":-2.072748,"marketCap":157381662},{"date":"2025-06-27","current":-2.200101,"twenty":-9.785504,"median":-2.271562,"eighty":-2.073948,"marketCap":156306161},{"date":"2025-07-03","current":-2.159732,"twenty":-9.684587,"median":-2.26468,"eighty":-2.075591,"marketCap":153438158},{"date":"2025-07-11","current":-2.361576,"twenty":-9.665383,"median":-2.263661,"eighty":-2.08254,"marketCap":167778173},{"date":"2025-07-18","current":-2.422129,"twenty":-9.609795,"median":-2.271562,"eighty":-2.08404,"marketCap":172080177},{"date":"2025-07-25","current":-2.371668,"twenty":-9.500638,"median":-2.280838,"eighty":-2.084673,"marketCap":168495173},{"date":"2025-08-01","current":-2.220285,"twenty":-9.464253,"median":-2.280838,"eighty":-2.088197,"marketCap":157740162},{"date":"2025-08-08","current":-1.959737,"twenty":-9.314668,"median":-2.269035,"eighty":-2.084673,"marketCap":154872159},{"date":"2025-08-15","current":-2.023247,"twenty":-9.295465,"median":-2.262157,"eighty":-2.074957,"marketCap":159891165},{"date":"2025-08-22","current":-2.041393,"twenty":-9.27525,"median":-2.258928,"eighty":-2.064982,"marketCap":161325166},{"date":"2025-08-29","current":-2.177486,"twenty":-9.225726,"median":-2.244642,"eighty":-2.064982,"marketCap":172080177},{"date":"2025-09-05","current":-2.136658,"twenty":-9.156998,"median":-2.24047,"eighty":-2.068612,"marketCap":168853674},{"date":"2025-09-12","current":-2.227387,"twenty":-9.141838,"median":-2.24047,"eighty":-2.071948,"marketCap":176023681},{"date":"2025-09-19","current":-2.368016,"twenty":-8.95182,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-09-26","current":-2.368016,"twenty":-8.818412,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-10-03","current":-2.676493,"twenty":-8.732502,"median":-2.244642,"eighty":-2.078994,"marketCap":211515218},{"date":"2025-10-10","current":-2.472354,"twenty":-3.102868,"median":-2.258928,"eighty":-2.082165,"marketCap":195382701},{"date":"2025-10-17","current":-2.318115,"twenty":-3.072547,"median":-2.260654,"eighty":-2.08404,"marketCap":183193689},{"date":"2025-10-24","current":-3.606461,"twenty":-3.072547,"median":-2.2657,"eighty":-2.08404,"marketCap":285007794},{"date":"2025-10-31","current":-3.50666,"twenty":-3.483977,"median":-2.271562,"eighty":-2.087206,"marketCap":277120786},{"date":"2025-11-07","current":-3.533398,"twenty":-3.483977,"median":-2.280838,"eighty":-2.091294,"marketCap":267799776},{"date":"2025-11-14","current":-3.65216,"twenty":-3.543352,"median":-2.287377,"eighty":-2.091294,"marketCap":276800885},{"date":"2025-11-21","current":-4.063738,"twenty":-3.690007,"median":-2.299357,"eighty":-2.092162,"marketCap":307994767},{"date":"2025-11-28","current":-4.489508,"twenty":-3.899107,"median":-2.309042,"eighty":-2.092231,"marketCap":340264301},{"date":"2025-12-05","current":-4.967317,"twenty":-4.069415,"median":-2.318115,"eighty":-2.105866,"marketCap":376477888},{"date":"2025-12-12","current":-6.031742,"twenty":-4.3315,"median":-2.319571,"eighty":-2.109405,"marketCap":457151721},{"date":"2025-12-19","current":-5.856703,"twenty":-5.07234,"median":-2.333015,"eighty":-2.111789,"marketCap":443885358},{"date":"2025-12-26","current":-6.660935,"twenty":-5.750734,"median":-2.336346,"eighty":-2.112399,"marketCap":504838920},{"date":"2026-01-02","current":-6.258819,"twenty":-5.908741,"median":-2.336346,"eighty":-2.11442,"marketCap":474362139},{"date":"2026-01-09","current":-6.585243,"twenty":-6.05445,"median":-2.344838,"eighty":-2.11744,"marketCap":499102115},{"date":"2026-01-16","current":-10.175903,"twenty":-6.388442,"median":-2.355734,"eighty":-2.117456,"marketCap":771241845},{"date":"2026-01-23","current":-10.411813,"twenty":-6.562534,"median":-2.368016,"eighty":-2.117456,"marketCap":789121720},{"date":"2026-01-30","current":-10.521991,"twenty":-6.660935,"median":-2.37516,"eighty":-2.117837,"marketCap":797472215},{"date":"2026-02-06","current":-11.006774,"twenty":-8.674889,"median":-2.403126,"eighty":-2.119987,"marketCap":834214390},{"date":"2026-02-13","current":-10.984738,"twenty":-9.153966,"median":-2.415588,"eighty":-2.124502,"marketCap":832544291},{"date":"2026-02-20","current":-11.094916,"twenty":-9.298497,"median":-2.422129,"eighty":-2.13258,"marketCap":840894786},{"date":"2026-02-27","current":-12.295855,"twenty":-9.537248,"median":-2.429257,"eighty":-2.136658,"marketCap":931915175},{"date":"2026-03-06","current":-11.22713,"twenty":-9.787979,"median":-2.458744,"eighty":-2.147751,"marketCap":850915379},{"date":"2026-03-13","current":-10.954439,"twenty":-10.064753,"median":-2.474292,"eighty":-2.150267,"marketCap":830247905},{"date":"2026-03-20","current":-11.590717,"twenty":-10.152544,"median":-2.496444,"eighty":-2.150267,"marketCap":878472010},{"date":"2026-03-27","current":-8.946976,"twenty":-10.175903,"median":-2.526002,"eighty":-2.154686,"marketCap":721170986},{"date":"2026-04-02","current":-9.761839,"twenty":-10.157216,"median":-2.545959,"eighty":-2.157168,"marketCap":786853020},{"date":"2026-04-10","current":-9.794874,"twenty":-10.109042,"median":-2.572155,"eighty":-2.15903,"marketCap":789515805},{"date":"2026-04-17","current":-9.354407,"twenty":-10.088448,"median":-2.581791,"eighty":-2.159654,"marketCap":754012003},{"date":"2026-04-24","current":-9.492053,"twenty":-10.157216,"median":-2.612676,"eighty":-2.159732,"marketCap":765106941},{"date":"2026-05-01","current":-9.281102,"twenty":-10.117474,"median":-2.677432,"eighty":-2.159732,"marketCap":748103216},{"date":"2026-05-08","current":-9.815385,"twenty":-10.117474,"median":-2.685566,"eighty":-2.162275,"marketCap":791169098},{"date":"2026-05-15","current":-9.250894,"twenty":-10.100274,"median":-2.711219,"eighty":-2.168441,"marketCap":831932916},{"date":"2026-05-22","current":-8.274644,"twenty":-10.088448,"median":-2.728907,"eighty":-2.172379,"marketCap":744138767},{"date":"2026-05-29","current":-8.427879,"twenty":-10.073417,"median":-2.779442,"eighty":-2.173018,"marketCap":757919114},{"date":"2026-06-05","current":-8.413049,"twenty":-10.064858,"median":-2.893147,"eighty":-2.175699,"marketCap":756585532},{"date":"2026-06-12","current":-8.131296,"twenty":-9.999175,"median":-2.971476,"eighty":-2.177486,"marketCap":731247474},{"date":"2026-06-18","current":-9.881131,"twenty":-10.021034,"median":-3.072547,"eighty":-2.177486,"marketCap":888610152},{"date":"2026-06-26","current":-11.18115,"twenty":-10.10449,"median":-3.377371,"eighty":-2.17969,"marketCap":1005520843},{"date":"2026-07-02","current":-11.991808,"twenty":-10.16483,"median":-3.4182,"eighty":-2.183022,"marketCap":1078423326},{"date":"2026-07-10","current":-12.30322,"twenty":-10.247258,"median":-3.447686,"eighty":-2.183492,"marketCap":1106428549},{"date":"2026-07-17","current":-10.953771,"twenty":-10.359979,"median":-3.495318,"eighty":-2.185281,"marketCap":985072585},{"date":"2026-07-24","current":-10.825252,"twenty":-10.509871,"median":-3.543352,"eighty":-2.186883,"marketCap":973514874},{"date":"2026-07-31","current":-12.283448,"twenty":-10.632169,"median":-3.606461,"eighty":-2.188179,"marketCap":1104650439},{"date":"2026-08-07","current":-5.30342,"twenty":-10.612701,"median":-3.697103,"eighty":-2.190009,"marketCap":500982312},{"date":"2026-08-14","current":-5.067589,"twenty":-10.521991,"median":-3.898161,"eighty":-2.190009,"marketCap":478704760},{"date":"2026-08-21","current":-4.708048,"twenty":-10.461393,"median":-3.973853,"eighty":-2.193232,"marketCap":444741048}],"updateTime":1787495302742},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637312872","title":"BioAge Labs to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312872","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312872?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:00","pubTimestamp":1779454800,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., May  22, 2026  (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) (\"BioAge\", \"the Company\"), a clinical-stage biotechnology company developing therapeutic product candidates for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300131/0/en/BioAge-Labs-to-Present-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786774","title":"BTIG Initiates BioAge Labs at Buy With $40 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786774","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786774?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:13","pubTimestamp":1778670802,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) has an average rating of overweight and mean price target of $51.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635368783","title":"BioAge Labs Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635368783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635368783?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:26","pubTimestamp":1778667960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 06:26 ET (10:26 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635200797","title":"BioAge Labs initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635200797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635200797?lang=en_us&edition=fundamental","pubTime":"2026-05-13 17:55","pubTimestamp":1778666109,"startTime":"0","endTime":"0","summary":"BTIG initiated coverage of BioAge Labs (BIOA) with a Buy rating and $40 price target BioAge is a clinical-stage biopharmaceutical company focused o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213137","title":"Earnings Beat: BioAge Labs, Inc. (NASDAQ:BIOA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213137","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213137?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:37","pubTimestamp":1778582225,"startTime":"0","endTime":"0","summary":"A week ago, BioAge Labs, Inc. ( NASDAQ:BIOA ) came out with a strong set of first-quarter numbers that could...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/earnings-beat-bioage-labs-inc-nasdaqbioa-just-beat-analyst-f","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/earnings-beat-bioage-labs-inc-nasdaqbioa-just-beat-analyst-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BIOA",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634313802","title":"Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634313802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634313802?lang=en_us&edition=fundamental","pubTime":"2026-05-12 02:20","pubTimestamp":1778523612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4007","LXEO","XLV","XBI","BK4581","LU0029874061.USD","BIOA","LU0128526141.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634236426","title":"BioAge Labs posts R&D Day presentation on BGE-102 program","url":"https://stock-news.laohu8.com/highlight/detail?id=2634236426","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634236426?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:10","pubTimestamp":1778519453,"startTime":"0","endTime":"0","summary":"BioAge Labs published an R&D Day presentation highlighting Phase 1 results for lead program BGE-102, an oral brain-penetrant NLRP3 inhibitor positioned for cardiometabolic disease.Presentation flagged 86% hsCRP reduction in obese subjects, with 87-93% achieving normalized hsCRP below 2 mg/L.Program profile included 24-hour IL-1β suppression of at least 90% at 60 mg once daily, with CNS penetration reported at about 0.7 Kp,uu CSF at 120 mg multiple ascending dose on day 14.Update outlined upcoming proof-of-concept readouts for cardiovascular risk in H2 2026, with diabetic macular edema proof-of-concept targeted for mid-2027.Company also highlighted an APJ agonist obesity program, with IND submission targeted for year-end 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL2rQJhj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634020034","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2634020034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634020034?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·ATL Braves C                                   1Q      (.78)   8:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["B","CBLL","CHRS","ANDG","BETA","BATRA","BODI","AGNT","BRCB","ASRT","BCAX","APC","BCSF","BIOA","COOK","AMTM","BTAI","ACH","ACXP","ACET","BATRK","BGS","ALLT","AMBQ","ABCL","CLLS","CEVA","ARMK","BALY","BLNK","CEG","CRCL","APEI","CGBD","ALGS","ASTS","ATRO","AEYE","ACHV","CVRX","ACM","CDRE","CERT","ABOS","DCGO","CINT","ACRS","ARVN","CLSK","AIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634440448","title":"Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634440448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634440448?lang=en_us&edition=fundamental","pubTime":"2026-05-10 21:50","pubTimestamp":1778421041,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","AMLX","PHVS","HCSG","XBI","XLV","BIOA","BK4588","LU0128526141.USD","BK4007","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633092450","title":"BioAge Labs reports Q1 EPS (52c), consensus (63c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633092450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633092450?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:21","pubTimestamp":1778253689,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $2.77M, consensus $1.08M. “The positive topline Phase 1 data we reported for BGE-102 in April reinforce our conviction that we h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-reports-q1-eps-52c-consensus-63c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-reports-q1-eps-52c-consensus-63c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143337615","title":"BioAge Labs Reports Q1 GAAP Loss of $0.52 Per Share on $2.8 Million Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1143337615","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143337615?lang=en_us&edition=fundamental","pubTime":"2026-05-08 22:51","pubTimestamp":1778251918,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company BioAge Labs Inc. has announced its financial results for the first quarter of 2026, reporting a GAAP loss per share of $0.52 and revenue of $2.8 million. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UUP","BK4007","UDN","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633454636","title":"BioAge Labs Q1 Loss Widens, Collaboration Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2633454636","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633454636?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:29","pubTimestamp":1778246953,"startTime":"0","endTime":"0","summary":"BioAge Labs  reported a Q1 loss Friday of $0.52 per diluted share, wider than a loss of $0.36 a year earlier.Analysts polled by FactSet expected a loss of $0.64.Collaboration revenue for the quarter ended March 31 was $2.8 million, up from $1.5 million a year earlier.Analysts surveyed by FactSet expected $1.1 million.BioAge said that as of March 31 it had about $384.9 million in cash, cash equivalents, and marketable securities, which it expects to be enough to fund operations through 2029.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633645198","title":"Bioage Labs Q1 EPS $(0.52) Beats $(0.64) Estimate, Sales $2.772M Beat $1.083M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633645198","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633645198?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:09","pubTimestamp":1778245796,"startTime":"0","endTime":"0","summary":"Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.64) by 18.75 percent. This is a 44.44 percent decrease over losses of $(0.36) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52407662/bioage-labs-q1-eps-0-52-beats-0-64-estimate-sales-2-772m-beat-1-083m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633961451","title":"BioAge Labs Q1 collaboration revenue beats estimates on Novartis collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2633961451","media":"Reuters","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633961451?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:09","pubTimestamp":1778245783,"startTime":"0","endTime":"0","summary":"BioAge Labs Q1 collaboration revenue beats estimates on Novartis collaborationOverviewUS biopharma firm's Q1 collaboration revenue rose, beating analyst expectationsNet loss widened on higher R&D expe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL1N41L0K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633714459","title":"Bioage Labs Inc Q1 Collaboration Revenue USD 2.772 Million VS. Ibes Estimate USD 1.32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633714459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633714459?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nPLXA6847F:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459717","title":"Bioage Labs Inc Q1 EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459717?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nPLXA6847F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633229451","title":"BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633229451","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633229451?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245200,"startTime":"0","endTime":"0","summary":"Positive topline Phase 1 data for BGE-102, demonstrating potential best-in-class reductions among oral NLRP3 inhibitors in inflammatory biomarkers of cardiovascular risk Phase 2 dose-ranging proof-of-","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/08/3291115/0/en/BioAge-Labs-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633969505","title":"BioAge hosts R&D Day webcast on BGE-102 NLRP3 inhibitor program","url":"https://stock-news.laohu8.com/highlight/detail?id=2633969505","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633969505?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:39","pubTimestamp":1777927157,"startTime":"0","endTime":"0","summary":"BioAge Labs to host an R&D Day webcast on May 8, 2026, starting 12:30 PM ET, focused on NLRP3 inhibition.Event set to feature Phase 1 clinical data for BGE-102, an oral NLRP3 inflammasome inhibitor.Company to outline development rationale for BGE-102 in atherosclerotic cardiovascular disease, plus retinal disease.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL1Zsc7l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BIOA","BK4588","LU2210149790.SGD","BK4585","BK4007","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629057230","title":"BioAge Labs announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2629057230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629057230?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:06","pubTimestamp":1776801989,"startTime":"0","endTime":"0","summary":"BioAge Labs schedules 2026 annual shareholder meeting for June 10, 2026, held virtually.Shareholders will vote on election of three Class II directors to three-year terms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL4y6hXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629054921","title":"Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Geron (GERN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629054921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629054921?lang=en_us&edition=fundamental","pubTime":"2026-04-22 02:40","pubTimestamp":1776796806,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on BioAge Labs, Inc. (BIOA) and Geron (GERN) with neutral ratings, indicating that the experts are neith...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-geron-gern-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-geron-gern-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","BK4588","GERN","LU0029874061.USD","BIOA","BK4137","XLV","BK4581","BK4007","XBI","BK4585","BK4139","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":105,"code":"91000000","status":"200"}]}}